Colgate-Palmolive Company $CL Stock: Investment House LLC Reduces Position

Investment House LLC trimmed its holdings in Colgate-Palmolive Company (NYSE:CL) by 71.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,710 shares of the company’s stock after selling 6,813 shares during the period. Investment House LLC’s holdings in Colgate-Palmolive were worth $231,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. State Street Corp increased its stake in shares of Colgate-Palmolive by 97.4% in the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after buying an additional 46,476,510 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Colgate-Palmolive by 172.5% during the 1st quarter. Bank of New York Mellon Corp now owns 12,521,545 shares of the company’s stock valued at $1,067,211,000 after acquiring an additional 7,927,238 shares during the last quarter. Bank of America Corp DE bought a new position in Colgate-Palmolive during the 2nd quarter valued at $567,483,000. Envestnet Asset Management Inc. grew its holdings in Colgate-Palmolive by 266.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 4,146,337 shares of the company’s stock worth $380,136,000 after acquiring an additional 3,014,860 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in Colgate-Palmolive by 151.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,276,774 shares of the company’s stock worth $364,894,000 after acquiring an additional 2,575,530 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on CL. TD Cowen boosted their price objective on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a report on Monday, August 3rd. BNP Paribas Exane dropped their price target on Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, September 28th. UBS Group set a $106.00 price objective on Colgate-Palmolive in a research note on Thursday, October 15th. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $103.00 to $104.00 and gave the stock an “overweight” rating in a report on Monday, October 19th. Finally, Citigroup boosted their target price on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Thirteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $98.00.

Colgate-Palmolive News Summary

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Analysts expect earnings growth, and Zacks says Colgate-Palmolive has a favorable combination of earnings estimates and historical earnings surprises that could support a quarterly beat. Colgate-Palmolive earnings expectations
• Positive Sentiment: Recent coverage has highlighted strong toothpaste performance, while Colgate-Palmolive India reported 12.2% revenue growth, 4.3% profit growth and modest gross-margin expansion. These results may offer some support for the broader brand portfolio, although the Indian subsidiary is not the same entity as the U.S.-listed parent. Colgate-Palmolive India quarterly results
• Neutral Sentiment: Options activity was elevated, with investors purchasing 4,443 put contracts—about 71% above typical volume—signaling increased hedging or bearish positioning ahead of the report, but not necessarily confirming a change in fundamentals.
• Neutral Sentiment: Institutional positioning was mixed in the latest quarter: 851 investors added shares while 853 reduced holdings. Analyst targets remain varied, with a reported median of $96, suggesting limited upside relative to recent trading levels.
• Negative Sentiment: Investors remain concerned about raw-material and packaging inflation, tariff effects, intense category competition and pressure on consumer spending. Management has also warned that volatile market conditions could persist through the rest of 2026. Colgate-Palmolive defensive rally and earnings risks
• Negative Sentiment: Insiders have reported five open-market sales and no purchases over the past six months, including substantial sales by CEO Noel Wallace. While insider transactions can reflect personal financial decisions, the lack of buying may weigh on sentiment.

Insider Buying and Selling

In other Colgate-Palmolive news, Director John Cahill sold 4,170 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares in the company, valued at $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 175,191 shares of company stock worth $16,110,903 in the last three months. 0.43% of the stock is owned by insiders.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $94.10 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The firm’s 50-day moving average price is $89.26 and its two-hundred day moving average price is $89.35. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock has a market capitalization of $75.02 billion, a P/E ratio of 37.34, a P/E/G ratio of 4.71 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. The company had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The business’s revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.92 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 84.13%.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.